GLUE — Monte Rosa Therapeutics, Inc. stock price, charts and financials

QT65Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.08
+0.70+4.55%
GLUEQT65Monte Rosa Therapeutics, Inc.·NASDAQ
16.08+4.55%
TA
Loading chart...
Short Interest History· Twice monthly
Settlement DateShort InterestAvg Daily VolumeShares FloatShort Float %Short Ratio
Jul-15-2617.20M1.16M59.76M28.77%14.82
Jun-30-2618.63M1.12M59.76M31.18%16.66
Jun-15-2617.17M1.02M59.76M28.73%16.78
May-29-2616.01M990.32K59.76M37.98%16.16
May-15-2614.96M1.02M59.76M35.51%14.69
Apr-30-2615.14M1.08M59.76M35.94%14.05
Apr-15-2615.84M1.13M59.76M37.58%14.05
Mar-31-2613.40M1.62M59.76M31.80%8.27
Mar-13-2610.96M1.60M59.76M26.02%6.87
Feb-27-2610.12M1.58M59.76M24.01%6.42
Feb-13-269.33M1.57M59.76M22.14%5.95
Jan-30-267.66M1.57M59.76M18.19%4.88